Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / ADR
-
Total 13F shares
-
253,598,053
-
Share change
-
-12,514,516
-
Total reported value
-
$10,835,627,801
-
Put/Call ratio
-
61%
-
Price per share
-
$42.74
-
Number of holders
-
711
-
Value change
-
-$557,317,025
-
Number of buys
-
326
-
Number of sells
-
301
Institutional Holders of GLAXOSMITHKLINE PLC - ADR (GSK) as of Q4 2014
As of 31 Dec 2014 GLAXOSMITHKLINE PLC - ADR (GSK) had 711 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 253,598,053 shares of stock of the company.
Largest 10 holders included Dodge & Cox, ROYAL BANK OF CANADA, HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC, FMR LLC, Fisher Asset Management, LLC, State Street Corp, WELLS FARGO & COMPANY/MN, PRICE T ROWE ASSOCIATES INC /MD/, Invesco Ltd., and Allianz Asset Management AG.
This table shows 712 institutional shareholders of the security as of 31 Dec 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.